Alsherbiny MA, Li CG. Medicinal cannabis-potential drug interactions. Medicines (Basel). 2018;6(1):–3. https://doi.org/10.3390/medicines6010003 PMID: 30583596; PMCID: PMC6473892.
Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2019;15(3):321–87. https://doi.org/10.1016/j.jalz.2019.01.010.
Article
Google Scholar
Alzheimer’s Disease International. World Alzheimer report 2019: attitudes to dementia. London; 2019. www.daviddesigns.co.uk. Accessed 25 Mar 2020.
Andrew C. Beck, Erica M. Lash, Jason B. Hack, Environmental toxic exposures using companion animals as an indicator of human toxicity: a case report and discussion, J Emergency Med, in press, https://doi.org/10.1016/j.jemermed.2020.04.026.
Beedham W, Sbai M, Allison I, Coary R, Shipway D. Cannabinoids in the older person: a literature review. Geriatrics. 2020;5(1):2. https://doi.org/10.3390/geriatrics5010002 PMID: 31941020; PMCID: PMC7151062.
Article
PubMed Central
Google Scholar
Bellows J, Center S, Daristotle L, Estrada AH, Flickinger EA, Horwitz DF, Shoveller AK. Aging in cats: common physical and functional changes. J Feline Med Surg. 2016;18(7):533–50 https://doi.org/10.1177/1098612X16649523.
Article
Google Scholar
Birch AM, Katsouri L, Sastre M. Modulation of inflammation in transgenic models of Alzheimer’s disease. J Neuroinflammation. 2014;11(1):25. https://doi.org/10.1186/1742-2094-11-25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci. 2011;124(2):225–50. https://doi.org/10.1093/toxsci/kfr239.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cassano T, Villani R, Pace L, Carbone A, Bukke VN, Orkisz S, Avolio C, Serviddio G. From Cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases. Front Pharmacol. 2020;11:124. https://doi.org/10.3389/fphar.2020.00124 PMCID: PMC7069528.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chambers JK, Tokuda T, Uchida K, Ishii R, Tatebe H, Takahashi E, Tomiyama T, Une Y, Nakayama H. The domestic cat as a natural animal model of Alzheimer’s disease. Acta Neuropathol Commun. 2015;3:78. https://doi.org/10.1186/s40478-015-0258-3 PMID: 26651821; PMCID: PMC4674944.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng D, Low JK, Logge W, Garner B, Karl T. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1ΔE9 mice. Psychopharmacology (Berl). 2014;231(15):3009–17. https://doi.org/10.1007/s00213-014-3478-5.
Article
CAS
PubMed
Google Scholar
M. M. Christopher, One Health, one literature: weaving together veterinary and medical research. Sci. Transl. Med. 7, 303 fs36 (2015). doi:https://doi.org/10.1126/scitranslmed.aab0215 pmid:26333932.
Cooray R, Gupta V, Suphioglu C. Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson’s and Alzheimer’s diseases: a review. Mol Neurobiol. 2020; https://doi.org/10.1007/s12035-020-02054-6.
Cummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ, et al. Diffuse plaques contain C-terminal Ab42 and not Ab40: evidence from cats and dogs. Neurobiology Aging. 1996;17(4):653e659 https://doi.org/10.1016/0197-4580(96)00062-0.
Google Scholar
Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals. 2019;9(10):832. https://doi.org/10.3390/ani9100832.
Article
Google Scholar
Devinsky O, Boesch JM, Cerda-Gonzalez S, et al. A cross-species approach to disorders affecting brain and behavior. Nat Rev Neurol. 2018;14:677–86 https://doi.org/10.1038/s41582-018-0074-z.
Article
Google Scholar
Drummond E, Wisniewski T. Alzheimer’s disease: experimental models and reality. Acta Neuropathol. 2017;133(2):155–75. https://doi.org/10.1007/s00401-016-1662-x.
Article
CAS
PubMed
Google Scholar
Epis R, Gardoni F, Marcello E, Genazzani A, Canonico PL, Di Luca M. Searching for new animal models of Alzheimer’s disease. Eur. J. Pharmacol. 2010;626:57–63. https://doi.org/10.1016/j.ejphar.2009.10.020.
Article
CAS
PubMed
Google Scholar
Esposito G, De Filippis D, Carnuccio R, Izzo AA, Iuvone T. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med (Berl). 2006;84(3):253–8. https://doi.org/10.1007/s00109-005-0025-1.
Article
CAS
PubMed
Google Scholar
Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, Cipriano M, Carratù MR, Iuvone T, Steardo L. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PloS one. 2011;6(12):e28668 https://doi.org/10.1371/journal.pone.0028668.
Article
CAS
Google Scholar
Fiock KL, Smith JD, Crary JF, Hefti MM. β-amyloid and tau pathology in the aging feline brain. J Comp Neurol. 2020;528(1):108–13. https://doi.org/10.1002/cne.24741.
Article
CAS
PubMed
Google Scholar
Foster JK, Verdile G, Bates KA, Martins RN. Immunization in Alzheimer’s disease: naïve hope or realistic clinical potential? Mol Psychiatry. 2009;14(3):239–51. https://doi.org/10.1038/mp.2008.115.
Article
CAS
PubMed
Google Scholar
Franco R, Cedazo-Minguez A. Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans? Front Pharmacol. 2014;5:146. https://doi.org/10.3389/fphar.2014.00146.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gibbs EPJ. The evolution of One Health: a decade of progress and challenges for the futureVeterinary. Record. 2014;174:85–91.
Article
Google Scholar
Gołaszewska A, Bik W, Motyl T, Orzechowski A. Bridging the gap between Alzheimer’s disease and Alzheimer’s-like diseases in animals. Int J Mol Sci. 2019;20(7). doi:https://doi.org/10.3390/ijms20071664.
Götz J, Ittner LM. Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9(7):532–44. https://doi.org/10.1038/nrn2420.
Article
CAS
PubMed
Google Scholar
Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer’s disease. J Neuroinflammation. 2011;8:26. https://doi.org/10.1186/1742-2094-8-26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gunn-Moore D, Danièlle P, Bsc G-M, Phd B, Macvsc F, Rcvs M. Increased vocalisation in elderly cats. Eur J Comp An Pr. 2015;25(3):20-29. http://www.ejcap.org. Accessed 25 Mar 2020.
Gunn-Moore D, Moffat K, Christie L-A, Head E. Cognitive dysfunction and the neurobiology of aging in cats. J Small Anim Pract. 2007;48(10):546–53. https://doi.org/10.1111/j.1748-5827.2007.00386.x.
Article
CAS
PubMed
Google Scholar
Gunn-Moore DA. Cognitive dysfunction in cats: clinical assessment and management. Top Companion Anim Med. 2011;26(1):17–24. https://doi.org/10.1053/j.tcam.2011.01.005.
Article
PubMed
Google Scholar
Gunn-Moore DA, McVee J, Bradshaw JM, Pearson GR, Head E, Gunn-Moore FJ. Aging changes in cat brains demonstrated by β-amyloid and AT8-immunoreactive phosphorylated tau deposits. J Feline Med Surg. 2006;8(4):234–42. https://doi.org/10.1016/j.jfms.2006.01.003.
Article
PubMed
Google Scholar
Hartsel JA, Boyar K, Pham A, Silver RJ, Makriyannis A., Cannabis in veterinary medicine: cannabinoid therapies for animals. In: Gupta R., Srivastava A. LR, ed. Nutraceuticals in veterinary medicine. Cham: Springer International Publishing; 2019:121-155. doi:https://doi.org/10.1007/978-3-030-04624-8_10.
Head E, Moffat K, Das P, et al. β-Amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging. 2005;26(5):749–63. https://doi.org/10.1016/j.neurobiolaging.2004.06.015.
Article
CAS
PubMed
Google Scholar
Hermush V, Ore L. An 81-year-old male with advanced dementia and recurrent cerebrovascular events: is there a place for cannabidiol therapy? Israel Med Assoc J. 2019;21(11):759–60 PMID: 31713367.
Google Scholar
Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2(1):139–54. https://doi.org/10.1089/can.2016.0034 PMID: 28861514; PMCID: PMC5569602.
Article
CAS
PubMed
PubMed Central
Google Scholar
Inglet S, Winter B, Yost SE, Entringer S, Lian A, Biksacky M, Pitt RD, Mortensen W. Clinical data for the use of cannabis-based treatments: a comprehensive review of the literature. Ann Pharmacother. 2020;54(11):1109–43. https://doi.org/10.1177/1060028020930189 Epub 2020 Jun 2. PMID: 32483988.
Article
PubMed
Google Scholar
Karagiannis C, Mills D. Feline cognitive dysfunction syndrome. Vet Focus. 2014;24(2):42-47.http://i.behaviour.gr/static/animalbehaviour/documents/feline-cognitive-dysfunction-syndrome.pdf. Accessed 25 Mar 2020.
Kim SH, Yang JW, Kim KH, Kim JU, Yook TH. A review on studies of marijuana for Alzheimer’s disease - focusing on CBD, THC. J Pharmacopuncture. 2019;22(4):225–30. https://doi.org/10.3831/KPI.2019.22.030 Epub 2019 Dec 31. PMID: 31970019; PMCID: PMC6970569.
Article
PubMed
PubMed Central
Google Scholar
Klug J, Snyder JM, Darvas M, Imai DM, Church M, Latimer C, Keene CD, Ladiges W. Aging pet cats develop neuropathology similar to human Alzheimer’s disease. Aging Pathobiology and Therapeutics. 2020;2(3):120–5.
Article
Google Scholar
Landsberg GM, Nichol J, Araujo JA. Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract. 2012;42(4):749–68, vii. https://doi.org/10.1016/j.cvsm.2012.04.003.
Article
PubMed
Google Scholar
Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J Neurosci. 2000;20(15):5709–14. https://doi.org/10.1523/jneurosci.20-15-05709.2000.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease. Mol Pharmacol. 2011;79(6):964-973. doi: https://doi.org/10.1124/mol.111.071290. Epub 2011 Feb 24. PMID: 21350020; PMCID: PMC3102548.
Morales I, Guzmán-Martínez L, Cerda-Troncoso C, Farías GA, Maccioni RB. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci. 2014;8(1 APR):112. doi:https://doi.org/10.3389/fncel.2014.00112.
Pastorinho MR, Sousa ACA. Pets as sentinels of human exposure to neurotoxic metals. In: Pets as sentinels, forecasters and promoters of human health. Springer International Publishing; 2020:83-106. doi:https://doi.org/10.1007/978-3-030-30734-9_5.
Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int. 2018;2018:1691428. doi: https://doi.org/10.1155/2018/1691428. PMID: 30627539; PMCID: PMC6304621.
Polson AG, Fuji RN. The successes and limitations of preclinical studies in predicting the pharmacodynamics and safety of cell-surface-targeted biological agents in patients. Br J Pharmacol. 2012;166(5):1600–2. https://doi.org/10.1111/j.1476-5381.2012.01916.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Poncelet L, Ando K, Vergara C, et al. A 4R tauopathy develops without amyloid deposits in aged cat brains. Neu- robiology of aging. 2019;81:200–12 https://doi.org/10.1016/j.neurobiolaging.2019.05.024.
Article
CAS
Google Scholar
Prpar Mihevc S, Majdič G. Canine cognitive dysfunction and Alzheimer’s disease - two facets of the same disease? Front Neurosci. 2019;13:604. https://doi.org/10.3389/fnins.2019.00604 PMID: 31249505; PMCID: PMC6582309.
Article
PubMed
PubMed Central
Google Scholar
Ritter S, Zadik-Weiss L, Almogi-Hazan O, Or R. Cannabis, One Health, and veterinary medicine: cannabinoids role in public health, food safety, and translational medicine. Rambam Maimonides Med J. 2020;11(1):e0006. https://doi.org/10.5041/RMMJ.10388.
Article
PubMed Central
Google Scholar
Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp Neurol. 2008;212(1):71–84. https://doi.org/10.1016/j.expneurol.2008.03.007 Epub 2008 Mar 21. 22.
Article
CAS
PubMed
Google Scholar
Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F. New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease modifying drugs. Br J Clin Pharmacol. 2012;73(4):504–17. https://doi.org/10.1111/j.1365-2125.2011.04134.x.
Article
CAS
PubMed
Google Scholar
Sarlus H, Heneka MT. Microglia in Alzheimer’s disease. J Clin Invest. 2017;127(9):3240–9. https://doi.org/10.1172/JCI90606.
Article
PubMed
PubMed Central
Google Scholar
Schneider B, Balbas-Martinez V, Jergens AE, Troconiz IF, Allenspach K, Mochel JP. Model-based reverse translation between veterinary and human medicine: the One Health Initiative. CPT pharmacometrics Syst Pharmacol. 2018;7(2):65–8. https://doi.org/10.1002/psp4.12262.
Article
CAS
PubMed
Google Scholar
Sultan SR, Millar SA, England TJ, O’Sullivan SE. A systematic review and meta-analysis of the haemodynamic effects of cannabidiol. Front Pharmacol. 2017;8(FEB). doi:https://doi.org/10.3389/fphar.2017.00081.
Takeuchi Y, Uetsuka K, Murayama M, et al. Complementary distributions of amyloid-β and neprilysin in the brains of dogs and cats. Veterinary Pathology. 2008;45(4):455–66.
Article
CAS
Google Scholar
Vallée A, Lecarpentier Y, Guillevin R, Vallée J-N. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochim Biophys Sin (Shanghai). 2017;49(10):853–66. https://doi.org/10.1093/abbs/gmx073.
Article
CAS
PubMed
Google Scholar
Watt G, Karl T. In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer’s disease. Front Pharmacol. 2017;8(FEB):20. doi:https://doi.org/10.3389/fphar.2017.00020.
Youssef SA, Capucchio MT, Rofina JE, et al. Pathology of the aging brain in domestic and laboratory animals, and animal models of human neurodegenerative diseases. Vet Pathol. 2016;53(2):327–48. https://doi.org/10.1177/0300985815623997.
Article
CAS
PubMed
Google Scholar